The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.

NCT01675453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Coronary Artery Disease
Edema

Interventions

DRUG: 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5
DRUG: 0.9% NaCl

Sponsor

Meshalkin Research Institute of Pathology of Circulation